SWP
ARCT icon

Stratos Wealth Partners’s Arcturus Therapeutics ARCT Stock Holding History

Stratos Wealth Partners’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,782
Closed -$301K – 1373
2023
Q3 		$301K Buy
+11,782
New +$363K 0.01% 1009

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Stratos Wealth Partners's ARCT Position: Q4 2023 in Review

Stratos Wealth Partners sold out of Arcturus Therapeutics (ARCT) in Q4 2023, closing a stake of 11,782 shares — an estimated $301K sold.

Stratos Wealth Partners first reported a position in ARCT in Q3 2023 and held it in 1 quarter. The position peaked at $301K in Q3 2023. 165 funds tracked by Wall St. Rank hold ARCT as of Q4 2023.

  • Stratos Wealth Partners reported no remaining Arcturus Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Stratos Wealth Partners sold 11,782 Arcturus Therapeutics shares in Q4 2023, an estimated $301K.
  • Stratos Wealth Partners first reported a position in Arcturus Therapeutics in Q3 2023 and held it in 1 quarter.
  • Stratos Wealth Partners's Arcturus Therapeutics position peaked at $301K in Q3 2023.
  • 165 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2023.

Based on Stratos Wealth Partners's 13F filing for Q4 2023, filed 24 Jan 2024.